310
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Bioengineering vascularized liver tissue for biomedical research and application

, , , &
Pages 623-629 | Received 30 Oct 2023, Accepted 20 Jan 2024, Published online: 06 Feb 2024

References

  • Jakab K, Norotte C, Damon B, et al. Tissue engineering by self-assembly of cells printed into topologically defined structures. Tissue Eng Part A. 2008;14(3):413–421. doi: 10.1089/tea.2007.0173.
  • Inamori M, Mizumoto H, Kajiwara T. An approach for formation of vascularized liver tissue by endothelial cell-covered hepatocyte spheroid integration. Tissue Eng Part A. 2009;15(8):2029–2037. doi: 10.1089/ten.tea.2008.0403.
  • Zhang J-S, Wang Z-B, Lai Z-Z, et al. Polyethylene glycol crosslinked decellularized single liver lobe scaffolds with vascular endothelial growth factor promotes angiogenesis in vivo. Hepatobiliary Pancreat Dis Int. 2023;22(6):622–631. doi: 10.1016/j.hbpd.2022.10.007.
  • Yang G, Mahadik B, Choi JY, et al. Vascularization in tissue engineering: fundamentals and state-of-art. Prog Biomed Eng. 2020;2(1):012002 (1-18). doi: 10.1088/2516-1091/ab5637.
  • Burr S, Caldwell A, Chong M, et al. Oxygen gradients can determine epigenetic asymmetry and cellular differentiation via differential regulation of tet activity in embryonic stem cells. Nucleic Acids Res. 2018;46(3):1210–1226. doi: 10.1093/nar/gkx1197.
  • Li H. Development of tissue‐engineered blood vessels. Tissue engineering for artificial organs: regenerative medicine. Smart Diag Per Med. 2017;1:325–361.
  • Lorente S, Hautefeuille M, Sanchez-Cedillo A. The liver, a functionalized vascular structure. Sci Rep. 2020;10(1):16194. doi: 10.1038/s41598-020-73208-8.
  • Nomi M, Atala A, Coppi PD, et al. Principals of neovascularization for tissue engineering. Mol Aspects Med. 2002;23(6):463–483. doi: 10.1016/s0098-2997(02)00008-0.
  • Solhi R, Lotfinia M, Gramignoli R, et al. Metabolic hallmarks of liver regeneration. Trends Endocrinol Metab. 2021;32(9):731–745. doi: 10.1016/j.tem.2021.06.002.
  • Zahmatkesh E, Ghanian MH, Zarkesh I, et al. Tissue-specific microparticles improve organoid microenvironment for efficient maturation of pluripotent stem-cell-derived hepatocytes. Cells. 2021;10(6):1274. doi: 10.3390/cells10061274.
  • Levenberg S, Rouwkema J, Macdonald M, et al. Engineering vascularized skeletal muscle tissue. Nat Biotechnol. 2005;23(7):879–884. doi: 10.1038/nbt1109.
  • Lammert E, Cleaver O, Melton D. Induction of pancreatic differentiation by signals from blood vessels. Science. 2001;294(5542):564–567. doi: 10.1126/science.1064344.
  • Adams RH, Wilkinson GA, Weiss C, et al. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev. 1999;13(3):295–306. doi: 10.1101/gad.13.3.295.
  • Patsch C, Challet-Meylan L, Thoma EC, et al. Generation of vascular endothelial and smooth muscle cells from human pluripotent stem cells. Nat Cell Biol. 2015;17(8):994–1003. doi: 10.1038/ncb3205.
  • Lucendo-Villarin B, Meseguer-Ripolles J, Drew J, et al. Development of a cost-effective automated platform to produce human liver spheroids for basic and applied research. Biofabrication. 2020;13(1):015009. doi: 10.1088/1758-5090/abbdb2.
  • Klimanskaya I, Kimbrel EA, Lanza R. Chapter 29 - Embryonic stem cells., In: R. Lanza, R. Langer, and J. Vacanti, Editors. Principles of tissue engineering. (Fourth Edition),. Academic Press: Boston; 2014, p. 565–579.
  • Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131(5):861–872. doi: 10.1016/j.cell.2007.11.019.
  • Vosough M, Ravaioli F, Zabulica M, et al. Applying hydrodynamic pressure to efficiently generate induced pluripotent stem cells via reprogramming of centenarian skin fibroblasts. PLOS One. 2019;14(4):e0215490. doi: 10.1371/journal.pone.0215490.
  • Hansel MC, et al. The use of induced pluripotent stem cells for the study and treatment of liver diseases. Curr Protoc Toxicol. 2016;67:14.13.1–14.13.27.
  • Zakikhan K, et al. In vitro generated hepatocyte-like cells: a novel tool in regenerative medicine and drug discovery. Cell J. 2017;19(2):204–217.
  • Tsuji O, Miura K, Okada Y, et al. Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proc Natl Acad Sci U S A. 2010;107(28):12704–12709. doi: 10.1073/pnas.0910106107.
  • Yasuda S, Kusakawa S, Kuroda T, et al. Tumorigenicity-associated characteristics of human iPS cell lines. PLOS One. 2018;13(10):e0205022. doi: 10.1371/journal.pone.0205022.
  • Miura K, Okada Y, Aoi T, et al. Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol. 2009;27(8):743–745. doi: 10.1038/nbt.1554.
  • Melchiorri AJ, Nguyen BN, Fisher JP. Mesenchymal stem cells: roles and relationships in vascularization. Tissue Eng Part B Rev. 2014;20(3):218–228. doi: 10.1089/ten.TEB.2013.0541.
  • Wu Q, Li Y, Yang Z, et al. Ectopic expansion and vascularization of engineered hepatic tissue based on heparinized acellular liver matrix and mesenchymal stromal cell spheroids. Acta Biomater. 2022;137:79–91. doi: 10.1016/j.actbio.2021.10.017.
  • Vosough M, Moslem M, Pournasr B, et al. Cell-based therapeutics for liver disorders. Br Med Bull. 2011;100(1):157–172. doi: 10.1093/bmb/ldr031.
  • Burdick JA, Mauck RL. Biomaterials for Tissue Engineering Applications: A Review of the Past and Future Trends. 2011. 1–564.
  • Wang N, Zhang R, Wang S-J, et al. Vascular endothelial growth factor stimulates endothelial differentiation from mesenchymal stem cells via rho/myocardin-related transcription factor–a signaling pathway. Int J Biochem Cell Biol. 2013;45(7):1447–1456. doi: 10.1016/j.biocel.2013.04.021.
  • Naftali-Shani N, et al. The origin of human mesenchymal stromal cells dictates their reparative properties. J Am Heart Assoc. 2013;2(5):e000253.
  • Darakhshan S, Bidmeshki Pour A, Kowsari-Esfahan R, et al. Generation of scalable hepatic micro-tissues as a platform for toxicological studies. Tissue Eng Regen Med. 2020;17(4):459–475. doi: 10.1007/s13770-020-00272-6.
  • Lee S, Ko J, Park D, et al. Microfluidic-based vascularized microphysiological systems. Lab Chip. 2018;18(18):2686–2709. doi: 10.1039/c8lc00285a.
  • Dash BC, Jiang Z, Suh C, et al. Induced pluripotent stem cell-derived vascular smooth muscle cells: methods and application. Biochem J. 2015;465(2):185–194. doi: 10.1042/BJ20141078.
  • Hesh CA, Qiu Y, Lam WA. Vascularized microfluidics and the blood-endothelium interface. Micromachines. 2019;11(1):18–35. doi: 10.3390/mi11010018.
  • Kim S, Lee H, Chung M, et al. Engineering of functional, perfusable 3D microvascular networks on a chip. Lab Chip. 2013;13(8):1489–1500. doi: 10.1039/c3lc41320a.
  • Kang YBA, Sodunke TR, Lamontagne J, et al. Liver sinusoid on a chip: long-term layered co-culture of primary rat hepatocytes and endothelial cells in microfluidic platforms. Biotechnol Bioeng. 2015;112(12):2571–2582. doi: 10.1002/bit.25659.
  • Du Y, Li N, Long M. Liver sinusoid on a chip. Methods Cell Biol. 2018;146:105–134.
  • Liu J, Zheng H, Poh PSP, et al. Hydrogels for engineering of perfusable vascular networks. Int J Mol Sci. 2015;16(7):15997–16016. doi: 10.3390/ijms160715997.
  • Dellaquila A, et al. In vitro strategies to vascularize 3D physiologically relevant models. Adv Sci. 2021;8(19):e2100798.
  • Heydari Z, Pooyan P, Bikmulina P, et al. Mimicking the liver function in micro-patterned units: challenges and perspectives in 3D bioprinting. Bioprinting. 2022;27:e00208. doi: 10.1016/j.bprint.2022.e00208.
  • Dellaquila A, Le Bao C, Letourneur D, et al. In vitro strategies to vascularize 3D physiologically relevant models. Adv Sci. 2021;8(19):2100798. doi: 10.1002/advs.202100798.
  • Heydari Z, Najimi M, Mirzaei H, et al. Tissue engineering in liver regenerative medicine: insights into novel translational technologies. Cells. 2020;9(2):304. doi: 10.3390/cells9020304.
  • Korff T, Augustin HG. Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J Cell Biol. 1998;143(5):1341–1352. doi: 10.1083/jcb.143.5.1341.
  • Vosough M, Omidinia E, Kadivar M, et al. Generation of functional hepatocyte-like cells from human pluripotent stem cells in a scalable suspension culture. Stem Cells Dev. 2013;22(20):2693–2705. doi: 10.1089/scd.2013.0088.
  • Fang Y, Eglen RM. Three-dimensional cell cultures in drug discovery and development. SLAS Discov. 2017;22(5):456–472. doi: 10.1177/1087057117696795.
  • Tao H, Han Z, Han ZC, et al. Proangiogenic features of mesenchymal stem cells and their therapeutic applications. Stem Cells Int. 2016. 2016;2016:1314709.
  • Horder H, Guaza Lasheras M, Grummel N, et al. Bioprinting and differentiation of Adipose-Derived stromal cell spheroids for a 3D breast cancer-adipose tissue model. Cells. 2021;10(4):803. doi: 10.3390/cells10040803.
  • Chen RR, Silva EA, Yuen WW, et al. Spatio-temporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm Res. 2007;24(2):258–264. doi: 10.1007/s11095-006-9173-4.
  • Oshikawa M, et al. Affinity-Immobilization of VEGF on laminin porous sponge enhances angiogenesis in the ischemic brain. Adv Healthc Mater. 2017;6(11):1700183 (1-6).
  • Kang D, Hong G, An S, et al. Bioprinting of multiscaled hepatic lobules within a highly vascularized construct. Small. 2020;16(13):e1905505. doi: 10.1002/smll.201905505.
  • Takebe T, Zhang R-R, Koike H, et al. Generation of a vascularized and functional human liver from an iPSC-derived organ bud transplant. Nat Protoc. 2014;9(2):396–409. doi: 10.1038/nprot.2014.020.
  • Kim HJ, Kim G, Chi KY, et al. In vitro generation of luminal vasculature in liver organoids: from basic vascular biology to vascularized hepatic organoids. Int J Stem Cells. 2022;16(1):1–15. doi: 10.15283/ijsc22154.
  • Rennert K, Steinborn S, Gröger M, et al. A microfluidically perfused three dimensional human liver model. Biomaterials. 2015;71:119–131. doi: 10.1016/j.biomaterials.2015.08.043.
  • Sakai Y, Yamanouchi K, Ohashi K, et al. Vascularized subcutaneous human liver tissue from engineered hepatocyte/fibroblast sheets in mice. Biomaterials. 2015;65:66–75. doi: 10.1016/j.biomaterials.2015.06.046.
  • Sasaki K, Akagi T, Asaoka T, et al. Construction of three-dimensional vascularized functional human liver tissue using a layer-by-layer cell coating technique. Biomaterials. 2017;133:263–274. doi: 10.1016/j.biomaterials.2017.02.034.
  • Teixeira FC, Chaves S, Torres AL, et al. Engineering a vascularized 3D hybrid system to model tumor-stroma interactions in breast cancer. Front Bioeng Biotechnol. 2021;9:647031. doi: 10.3389/fbioe.2021.647031.
  • Lin M, Gao M, Cavnar MJ, et al. Utilizing gastric cancer organoids to assess tumor biology and personalize medicine. World J Gastrointest Oncol. 2019;11(7):509–517. doi: 10.4251/wjgo.v11.i7.509.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.